Cabaletta Bio, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Leases (Tables)

Leases (Tables)

12 Months Ended

Dec. 31, 2024

Schedule of Future Minimum Payments for Operating Leases

Future lease payments under the non-cancelable operating and finance leases as of December 31, 2024 are as follows:


	Finance Leases			Operating Leases
2025	$	6,328		$	4,227
2026		3,792			2,769
Total undiscounted lease payments		10,120			6,996
Less imputed interest		(890	)		(626	)
Total lease liability	$	9,230		$	6,370

Schedule of Company's Operating and Finance Leases

The following table contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the Company’s operating and finance leases for the years ended December 31, 2024 and 2023.


	For the year ended December 31,
	2024			2023
Finance leases
Interest expense	$	748		$	—
Amortization expense		3,102			—
Total fixed finance lease cost	$	3,850		$	—
Variable lease cost		930			—
Total finance lease cost	$	4,780		$	—
Operating leases
Fixed lease cost	$	3,247		$	2,477
Total fixed operating lease cost	$	3,247		$	2,477
Variable lease cost		296			65
Short-term lease cost		750			717
Total operating lease cost	$	4,293		$	3,259

Cash paid in the measurement of lease liabilities
Operating cash flows used for operating leases	$	3,291		$	2,456
Operating cash flows used for finance leases		748			—
Financing cash flows for finance leases		897			—
Other information
Weighted average remaining lease term - finance leases (in years)		1.7			—
Weighted average discount rate - finance leases		11.5	%		—
Weighted average remaining lease term - operating leases (in years)		1.7			1.5
Weighted average discount rate - operating leases		11.0	%		9.5	%